Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    syn115
Show Display Options
Rank Status Study
1 Completed Study to Evaluate SYN115 in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Placebo;   Drug: Tozadenant
2 Completed Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Condition: Parkinson's Disease
Interventions: Drug: Tozadenant (SYN115) 60 mg BID;   Drug: Placebo;   Drug: Levodopa (L-dopa);   Drug: Tozadenant (SYN115) 120 mg BID;   Drug: Tozadenant (SYN115) 180 mg BID;   Drug: Tozadenant (SYN115) 240 mg BID
3 Completed An fMRI Study of SYN115 in Cocaine Dependent Subjects
Condition: Cocaine Dependence
Interventions: Drug: SYN115;   Drug: PLACEBO
4 Completed Study to Evaluate the Absorption, Distribution, Break Down and Elimination and the Safety of 14C-Labeled Tozadenant
Condition: N/A, as Healthy Volunteers
Interventions: Drug: tozadenant tablet;   Drug: C14-tozadenant capsule
5 Recruiting Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients Using Levodopa
Condition: Idiopathic Parkinson's Disease
Interventions: Drug: tozadenant;   Drug: placebo

Study has passed its completion date and status has not been verified in more than two years.